Northwest Biotherapeutics Inc Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -227,490.00%-344,350.00%-7,418.01%-6,961.19%-7,024.69%-7,500.69%-13,336.12%-17,923.51%-12,464.08%-1,284.40%-7,370.18%-5,742.59%-4,352.29%-3,144.36%-5,374.46%
EBIT Margin -153,540.00%-267,870.00%-5,676.81%-6,857.11%-6,956.19%-7,261.87%-12,723.27%-16,273.21%-10,068.20%-1,160.95%-6,708.37%-5,243.98%-3,991.74%-2,873.08%-4,812.45%
EBITDA Margin -153,540.00%-267,870.00%-5,676.81%-6,857.11%-6,955.50%-7,261.87%-12,723.27%-16,273.21%-10,068.20%-1,160.95%-6,708.37%-5,243.98%-3,991.74%-3,415.22%-6,055.35%
Operating Margin -153,540.00%-267,870.00%-5,676.81%-6,857.11%-6,956.19%-7,261.87%-12,723.27%-16,273.21%-10,068.20%-1,160.95%-6,708.37%-5,243.98%-3,991.74%-2,873.08%-4,812.45%
Net Margin 9,170.00%-273,680.00%-328,300.00%-8,720.21%-8,132.14%-7,024.69%-6,598.10%-13,781.86%-22,145.54%-12,999.76%-863.57%-41,039.58%17,823.48%-6,240.76%-3,331.94%-6,164.40%
FCF Margin -46,770.00%-64,170.00%-147,560.00%-2,951.42%-4,672.31%-6,073.11%-4,971.94%-9,725.68%-10,863.99%-8,394.66%-1,336.89%-2,997.91%-4,409.35%-3,308.20%-2,954.14%-4,199.06%
Efficiency
Assets Average 0.25M3.89M13.18M37.62M63.63M61.85M50.91M36.79M17.66M21.77M36.53M35.74M29.59M27.30M
Equity Average -92.66M-10.42M-26.16M-34.12M-12.95M-22.42M-19.85M-15.59M-46.92M-57.73M-46.59M-204.00M-243.47M-126.05M-96.94M-80.13M
Invested Capital -20.69M-4.25M-52.17M-11.21M-1.13M9.71M23.31M5.21M-35.90M-18.14M-24.84M-7.98M-17.21M-47.54M-56.59M-84.91M
Asset Utilization Ratio 0.040.200.060.040.030.010.010.010.140.060.030.050.070.05
Leverage & Solvency
Interest Coverage Ratio -1.95-3.50-3.26-65.88-101.55-30.41-20.76-9.86-4.20-9.40-10.14-10.52-11.07-10.59-8.56
Debt to Equity -0.1320.590.00-0.30-0.88-1.45-5.98-0.48-0.63-0.66-0.59-1.00-1.06-0.68-0.45-0.23
Debt Ratio -10.720.940.640.460.900.400.240.871.302.5211.053.292.761.060.82
Equity Ratio -0.52-246.10-2.12-0.52-0.62-0.07-0.50-1.38-1.95-4.23-11.03-3.09-4.09-2.36-3.54
Times Interest Earned -1.95-3.50-3.26-65.88-101.55-30.41-20.76-9.86-4.20-9.40-10.14-10.52-11.07-10.59-8.56
Dividends & Payouts
FCF Payout Ratio 0.27
Valuation
Enterprise Value 46.84M56.99M36.59M70.92M126.67M318.61M272.85M35.74M75.69M84.04M125.01M1,105.55M634.28M818.47M806.72M348.14M
Market Capitalization 45.87M56.10M36.61M77.24M145.17M332.87M295.55M43.29M75.81M106.27M125.38M1,115.54M649.45M825.44M808.85M350.31M
Return Ratios
Return on Sales -74.18%-69.61%-70.25%-75.01%-133.36%-179.24%-124.64%-12.84%-73.70%-57.43%-43.52%-31.44%-53.74%
Return on Capital Employed 0.53%6.40%8.52%2.71%96.88%5.45%1.49%1.25%1.05%0.24%0.54%0.74%3.56%1.62%
Return on Assets -136.11%-14.72%-4.27%-2.72%-2.05%-1.34%-1.18%-1.40%-1.75%-4.37%-1.58%-2.05%-2.05%-2.72%
Return on Equity 2.18%1.32%1.68%4.35%4.56%6.57%5.33%1.28%0.89%0.66%0.47%0.24%0.58%0.63%0.93%